Jul 21, 2022
87:83
For every 83 shares held, investors received 87. The price per share adjusted from $6.96 to $6.64.
The split itself did not change the total investment value.
Gennex Laboratories Limited (BSE:GENNEX) operates in the Pharmaceuticals: major industry.
Gennex Laboratories Limited company overviewGennex Laboratories Limited's most recent stock split was on July 21, 2022. It was a 87-for-83 forward split, so shareholders received 87 shares for every 83 they held.
Gennex Laboratories Limited (BSE:GENNEX) has split its stock 2 times: a 10-for-1 split on December 14, 2009 and a 87-for-83 split on July 21, 2022.
Gennex Laboratories Limited has split its stock 2 times. This history records 2 forward splits between December 14, 2009 and July 21, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Gennex Laboratories Limited's 87-for-83 split on July 21, 2022, every 83 shares became 87 shares.
Gennex Laboratories Limited has not announced a new split in our records. Its most recent split was on July 21, 2022, 4 years ago. Companies announce splits in advance, and any new BSE:GENNEX split will appear on this page.
Already premium?